ecancer

NETTER-1: Targeted radionuclide therapy improves PFS in mid-gut NETs

Prof Philippe Ruszniewski - Paris Diderot University, Paris, France

27 Sep 2015

RADIANT-4: Results of international trial show promise in the treatment of neuroendocrine tumours

Prof James Yao - University of Texas MD Anderson Cancer Center, Houston, USA

27 Sep 2015

Mid-gut NETs respond to targeted radionuclide therapy: NETTER-1 results

Prof Philippe Ruszniewski - Paris Diderot University, Paris, France

27 Sep 2015

Everolimus for non-functional neuroendocrine tumours

Prof James Yao - University of Texas MD Anderson Cancer Center, Houston, USA

26 Sep 2015

The p-medicine project and ECRIN

Jacques Demotes - ECRIN

2 Sep 2015

Highlights of the p-medicine project

2 Sep 2015

Investigational ER degrader safe, with early signs of antitumour activity against advanced ER-positive breast cancer

Dr Maura Dickler - Memorial Sloan Kettering Cancer Center, New York, USA

1 May 2015

The role of health economics in cancer outcomes research

Prof Bengt Jönsson, Stockholm School of Economics, Stockholm, Sweden

6 Jan 2015

Biobanking biological materials and linkage to clinical information

Dr Peter Riegman, Erasmus Medical Center, Rotterdam, The Netherlands

6 Jan 2015

2nd EurocanPlatform translational research course is good for networking

Dr Diana Montezuma, Portuguese Oncology Institute of Porto, Portugal

6 Jan 2015

Reasons to attend the EurocanPlatform translational research course 2015

Dr Wilfried Reichardt, University Medical Center Freiburg, Freiburg, Germany

6 Jan 2015

Immunotherapy of cancer: recent progress and future challenges

Prof Rolf Kiessling, Karolinska Institutet, Stockholm, Sweden

6 Jan 2015

More from ecancer